Number and geographic location (continent) of active pharmaceutical ingredient (API) manufacturing sites and related medicinal products
| Pharmaceutical substance | API manufacturing sites per continent (n) | Related authorised medicinal products per continent (n) | |||||
| Total | Europe | Other continents | Total | Europe | Europe and other continents* | Other continents | |
| Overall | 90 | 38 (42%) | 52 (58%) | 407 | 146 (36%) | 139 (34%) | 122 (30%) |
| Amoxicillin | 6 | 3 (50%) | 3 (50%) | 32 | 24 (75%) | 0 (0%) | 8 (25%) |
| Colecalciferol | 5 | 3 (60%) | 2 (40%) | 82 | 47 (57%) | 18 (22%) | 17 (21%) |
| Desloratadine | 15 | 3 (20%) | 12 (80%) | 34 | 0 (0%) | 15 (44%) | 19 (56%) |
| Diclofenac | 8 | 3 (38%) | 5 (62%) | 29 | 7 (24%) | 3 (10%) | 19 (66%) |
| Levonorgestrel/ethinylestradiol | 4 | 4 (100%) | 0 (0%) | 21 | 21 (100%) | 0 (0%) | 0 (0%) |
| 4 | 4 (100%) | ||||||
| Metoprolol | 13 | 6 (46%) | 7 (54%) | 34 | 13 (38%) | 16 (47%) | 5 (15%) |
| Omeprazole | 12 | 6 (50%) | 6 (50%) | 85 | 14 (16%) | 56 (66%) | 15 (18%) |
| Pantoprazole | 17 | 4 (24%) | 13 (76%) | 33 | 0 (0%) | 16 (48%) | 17 (52%) |
| Salbutamol | 6 | 5 (83%) | 1 (17%) | 21 | 20 (95%) | 0 (0%) | 1 (5%) |
| Simvastatin | 11 | 2 (18%) | 9 (82%) | 36 | 0 (0%) | 15 (42%) | 21 (58%) |
*The regulatory dossier for an authorised medicinal product may list several API manufacturers on different continents.